Schizophyllan-containing cosmetic for repairing skin injury as well as preparation method and composition of schizophyllan-containing cosmetic

By using the synergistic cooperation of cracked polysaccharides, sea cucumber polypeptides and recombinant collagen in cosmetics, the problem of skin lesions repair is solved, and the skin moisture retention and barrier function is significantly improved, and effective skin repair effects are achieved.

CN118902888APending Publication Date: 2024-11-08GUANGDONG MARUBI BIOLOGICAL TECH CO LTD
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
CN202411329786.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-23
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing cosmetics are difficult to effectively repair skin damage, resulting in loss of skin moisture and decreased barrier function, affecting the appearance and elasticity of the skin.

Method used

Cosmetic formulas containing cleavage polysaccharides, sea cucumber polypeptides and recombinant collagen are used to improve the moisture content of the skin stratum corneum and skin barrier function to provide skin repair effects.

Benefits of technology

Significantly improve the moisture content of the skin's stratum corneum, reduce the percutaneous moisture loss rate of the skin, enhance the skin barrier function, improve the skin's repair effect, and improve the skin's absorption and retention of the active ingredients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118902888A_ABST
    Figure CN118902888A_ABST
Patent Text Reader

Abstract

The invention relates to the field of cosmetics, in particular to a schizophyllan-containing cosmetic for repairing skin injury and a preparation method and composition thereof. The cosmetic comprises the following components in percentage by mass: 2-10% of a schizophyllan solution; 0.01%-0.1% of a sea cucumber polypeptide solution; and 0.01%-0.1% of a recombinant collagen solution. According to the technical scheme, the novel cosmetic containing the schizophyllan and used for repairing the skin injury is provided, and the skin injury can be effectively repaired. In the technical scheme, the schizophyllan solution (SPG), the sea cucumber polypeptide and the type I and type III mixed collagen are cooperated to realize a synergistic interaction effect; the skin cuticle water content and the skin transdermal moisture loss rate can be greatly improved, so that the skin barrier effect is improved; the skin repairing effect is realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of cosmetics, and in particular, to a cosmetic containing Schizophyllan for repairing skin damage, and a preparation method and composition thereof. Background Art

[0002] Skin damage occurs when the skin loses moisture and the skin barrier is damaged. Skin damage directly affects the appearance of the skin. The pores become larger and even the elasticity of the skin decreases.

[0003] Therefore, it is necessary to develop cosmetics for repairing skin damage. Summary of the invention

[0004] The purpose of the embodiments of the present application is to provide a cosmetic containing Schizophyllan for repairing skin damage, and a preparation method and composition thereof.

[0005] In a first aspect, the present application provides a cosmetic for repairing skin damage comprising Schizophyllan, which comprises, by 100% by mass:

[0006] Glycerol 5%-15%;

[0007] Panthenol 0.5%-1.5%;

[0008] Butanediol 1% to 5%;

[0009] Glyceryl polyether-26 1%~5%;

[0010] Acrylic acid (esters) / C10-30 alkyl acrylate crosspolymer 0.1% to 0.5%;

[0011] Dipotassium glycyrrhizinate 0.1%~0.5%;

[0012] Schizophyllan solution 2% to 10%;

[0013] Rice fermentation product filtrate 0.5% to 1.5%;

[0014] Aminomethyl propanol solution 0.01% to 0.1%;

[0015] Tetrahydromethylpyrimidine carboxylic acid 0.5% to 1.5%;

[0016] Ascorbyl palmitate 0.0005% to 0.002%;

[0017] Lactobacillus / soy milk fermentation product filtrate 0.0005% to 0.002%;

[0018] 0.1% to 1% mixture of chamomile flower extract, mallow flower extract, peony root extract, honeysuckle flower extract, dandelion rhizome / root extract, Viola yedoensis extract, and aloe barbadensis leaf juice;

[0019] Glyceryl glucoside 0.1% to 1%;

[0020] Tetrapeptide-1 0.0005%~0.002%;

[0021] Glycosphingolipids 0.0005% to 0.002%;

[0022] Sea cucumber polypeptide solution 0.01%~0.1%;

[0023] 0.01% to 0.1% recombinant collagen solution; and the balance water.

[0024] The above technical solution provides a new cosmetic containing Schizophyllan for repairing skin damage, which can effectively repair skin damage.

[0025] In the above technical scheme, schizophyllan solution (SPG), sea cucumber polypeptide, and mixed collagen types I and III work together to achieve a synergistic effect; it can greatly improve the water content of the skin's stratum corneum and the skin's transepidermal water loss rate, thereby improving the skin's barrier function and achieving skin repair effects.

[0026] Furthermore, in the above technical scheme, the various ingredients in the cosmetics cooperate synergistically to make the cosmetics mild and non-irritating, which is beneficial to skin absorption; and the synergistic cooperation of schizophyllan solution (SPG), sea cucumber polypeptide, and type I and III mixed collagen is beneficial to the retention of other effective ingredients; it is beneficial to further improve the skin's absorption of effective ingredients.

[0027] Furthermore, the above-mentioned cosmetics have a refreshing skin feel and are particularly suitable for products such as essences, which are beneficial to skin absorption.

[0028] In other embodiments of the present application, in the above-mentioned recombinant collagen solution, the mass concentration of the recombinant collagen is 0.01 mg / mL-5 mg / mL.

[0029] In other embodiments of the present application, in the above-mentioned recombinant collagen solution, the mass concentration of the recombinant collagen is 0.01 mg / mL-0.1 mg / mL.

[0030] In other embodiments of the present application, the above-mentioned recombinant collagen includes: at least one of type I recombinant collagen and type III recombinant collagen.

[0031] In other embodiments of the present application, in the above-mentioned sea cucumber polypeptide solution, the molar concentration of the sea cucumber polypeptide is 1 μmol / L-10 μmol / L.

[0032] In other embodiments of the present application, in the above-mentioned sea cucumber polypeptide solution, the molecular weight of the sea cucumber polypeptide is 900Da-1000Da.

[0033] In other embodiments of the present application, in the above-mentioned Schizophyllan solution, the mass concentration of Schizophyllan is 20 μg / mL to 800 μg / mL.

[0034] In other embodiments of the present application, in the above-mentioned Schizophyllan solution, the mass concentration of Schizophyllan is 200 μg / mL to 600 μg / mL.

[0035] In a second aspect, the present application provides a method for preparing a cosmetic containing Schizophyllan for repairing skin damage, comprising:

[0036] Boil tetrahydromethylpyrimidine carboxylic acid, add it into water, and stir until transparent to obtain a pre-made raw material;

[0037] Add water, glycerin, panthenol, butylene glycol, glyceryl polyether-26, acrylates / C10-30 alkyl acrylate crosspolymer, dipotassium glycyrrhizinate, schizophyllan solution, and rice fermentation product filtrate into a water phase pot, raise the temperature to 80-90° C., and keep the temperature for 5-15 minutes to obtain a first mixture;

[0038] The first mixture is added into an emulsifying pot and homogenized to obtain a second mixture;

[0039] Cooling the second mixture to 40-50° C.; adding the pre-prepared raw materials, ascorbyl palmitate, lactobacillus / soy milk fermentation product filtrate, chamomile flower extract, malva sylvestris flower extract, peony root extract, honeysuckle flower extract, dandelion rhizome / root extract, Viola yedoensis extract, a mixture of aloe vera leaf juice, glyceryl glucoside, tetrapeptide-1, glycosphingolipids, sea cucumber polypeptide solution, and recombinant collagen solution, and homogenizing to obtain a third mixture;

[0040] The third mixture was cooled to 30-40°C.

[0041] In other embodiments of the present application, the above-mentioned preparation of the Schizophyllan solution includes:

[0042] removing the bacterial bodies from the Schizophyllum fermentation liquid to obtain a fermentation supernatant;

[0043] The fermentation supernatant is decolorized, deproteinized and desalted to obtain a transparent fermentation supernatant;

[0044] Concentrating the transparent fermentation supernatant to 30% to 50% of the volume of the original solution to obtain a concentrated liquid;

[0045] removing free proteins from the concentrated liquid to obtain a schizophyllan solution;

[0046] The schizophyllan solution is subjected to alcohol precipitation to obtain a deproteinized flocculent polysaccharide; the deproteinized flocculent polysaccharide is redissolved to obtain a reconstituted liquid; the reconstituted liquid is dialyzed and freeze-dried to obtain a powder; and the powder is redissolved with water.

[0047] In a third aspect, the present application provides a composition comprising Schizophyllan, comprising:

[0048] Schizophyllum polysaccharide, sea cucumber polypeptide, recombinant collagen;

[0049] The mass concentration of recombinant collagen is 0.01-5 mg / mL;

[0050] The molar concentration of sea cucumber polypeptides is 1μmol / L-10μmol / L;

[0051] The mass concentration of Schizophyllan is 20 μg / mL to 800 μg / mL. BRIEF DESCRIPTION OF THE DRAWINGS

[0052] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the embodiments will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present application and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.

[0053] Figure 1 The effect of SPG on the proliferation of HaCaT cells in the present application example;

[0054] Figure 2 The effect of sea cucumber polypeptide on HaCaT cell proliferation in the examples of this application;

[0055] Figure 3 This is the effect of recombinant type I and III mixed collagen on the proliferation of HaCaT cells in the examples of this application;

[0056] Figure 4 The effect of SPG on the proliferation of BJ cells in the present application example;

[0057] Figure 5 The effect of sea cucumber polypeptide on BJ cell proliferation in the examples of this application;

[0058] Figure 6 This is the effect of recombinant type I and III mixed collagen on BJ cell proliferation in the examples of this application;

[0059] Figure 7 It is one of the response surfaces of BJ cell proliferation of the three materials in the examples of this application;

[0060] Figure 8 This is the second of the response surfaces of the three material formulations of the present application example to the proliferation of BJ cells;

[0061] Fig. 9 This is the third of the response surfaces of the three material formulations in the examples of this application on BJ cell proliferation. DETAILED DESCRIPTION

[0062] In order to make the purpose, technical solutions and advantages of the embodiments of the present application clearer, the technical solutions in the embodiments of the present application will be clearly and completely described below. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments.

[0063] Therefore, the following detailed description of the embodiments of the present application is not intended to limit the scope of the present application for protection, but merely represents selected embodiments of the present application. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present application.

[0064] The embodiment of the present application provides a cosmetic for repairing skin damage containing Schizophyllan, which comprises, by 100% by mass:

[0065] Glycerol 5%-15%;

[0066] Panthenol 0.5%-1.5%;

[0067] Butanediol 1% to 5%;

[0068] Glyceryl polyether-26 1%~5%;

[0069] Acrylic acid (esters) / C10-30 alkyl acrylate crosspolymer 0.1% to 0.5%;

[0070] Dipotassium glycyrrhizinate 0.1%~0.5%;

[0071] Schizophyllan solution 2% to 10%;

[0072] Rice fermentation product filtrate 0.5% to 1.5%;

[0073] Aminomethyl propanol solution 0.01% to 0.1%;

[0074] Tetrahydromethylpyrimidine carboxylic acid 0.5% to 1.5%;

[0075] Ascorbyl palmitate 0.0005% to 0.002%;

[0076] Lactobacillus / soy milk fermentation product filtrate 0.0005% to 0.002%;

[0077] 0.1% to 1% mixture of chamomile flower extract, mallow flower extract, peony root extract, honeysuckle flower extract, dandelion rhizome / root extract, Viola yedoensis extract, and aloe barbadensis leaf juice;

[0078] Glyceryl glucoside 0.1% to 1%;

[0079] Tetrapeptide-1 0.0005%~0.002%;

[0080] Glycosphingolipids 0.0005% to 0.002%;

[0081] Sea cucumber polypeptide solution 0.01%~0.1%;

[0082] 0.01% to 0.1% recombinant collagen solution; and the balance water.

[0083] In the above technical solution, a new cosmetic containing Schizophyllan for repairing skin damage is provided, which can effectively repair skin damage.

[0084] In the above technical solution, Schizophyllan solution (SPG), sea cucumber polypeptide, and mixed collagen type I and III cooperate to achieve a synergistic effect; it can greatly improve the water content of the stratum corneum and the transepidermal water loss rate of the skin, thereby improving the skin barrier effect; and achieving skin repair effect. Further optionally, exemplarily, in some embodiments of the present application, a cosmetic containing Schizophyllan for repairing skin damage, measured by 100% by mass, includes:

[0085] Glycerol 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15% or the range between any two of the foregoing values;

[0086] Panthenol 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1.0%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5% or the range between any two of the foregoing values;

[0087] Butanediol 1%, 1.2%, 1.5%, 1.8%, 2%, 2.2%, 2.5%, 2.8%, 3%, 3.5%, 3.8%, 4%, 4.5%, 4.8%, 5% or the range between any two of the foregoing values;

[0088] Glycereth-26 1%, 1.2%, 1.5%, 1.8%, 2%, 2.2%, 2.5%, 2.8%, 3%, 3.2%, 3.5%, 3.8%, 4%, 4.2%, 4.5%, 4.8%, 5% or the range between any two of the foregoing values;

[0089] Acrylates / C10-30 Alkyl Acrylate Crosspolymer 0.1%, 0.15%, 0.2%, 0.22%, 0.25%, 0.3%, 0.35%, 0.4%, 0.42%, 0.45%, 0.48%, 0.5% or the range between any two of the foregoing values;

[0090] Dipotassium glycyrrhizinate 0.1%, 0.15%, 0.2%, 0.22%, 0.25%, 0.3%, 0.35%, 0.4%, 0.42%, 0.45%, 0.48%, 0.5% or the range between any two of the foregoing values;

[0091] Schizophyllan solution 2%, 2.2%, 2.5%, 2.8%, 3%, 3.2%, 3.5%, 3.8%, 4%, 4.2%, 4.5%, 4.8%, 5%, 5.2%, 5.5%, 5.8%, 6%, 6.2%, 6.5%, 6.8%, 7%, 7.2%, 7.5%, 7.8%, 8%, 8.2%, 8.5%, 8.8%, 8.9%, 9%, 9.2%, 9.5%, 9.8%, 10% or the range between any two of the foregoing values;

[0092] 0.5%, 0.6%, 0.8%, 1%, 1.2%, 1.3%, 1.4%, 1.5% of rice fermentation product filtrate or the range between any two of the foregoing values;

[0093] Aminomethyl propanol solution 0.01%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1% or the range between any two of the foregoing values;

[0094] Tetrahydromethylpyrimidine carboxylic acid 0.5%, 0.6%, 0.8%, 0.9%, 1%, 1.2%, 1.3%, 1.4%, 1.5% or the range between any two of the foregoing values;

[0095] Ascorbyl palmitate 0.0005%, 0.0006%, 0.0007%, 0.0008%, 0.0009%, 0.001%, 0.0012%, 0.0015%, 0.0018%, 0.002% or the range between any two of the foregoing values;

[0096] 0.0005%, 0.0006%, 0.0007%, 0.0008%, 0.0009%, 0.001%, 0.0012%, 0.0015%, 0.0018%, 0.002% of Lactobacillus / soymilk fermentation product filtrate or the range between any two of the foregoing values;

[0097] A mixture of 0.1%, 0.15%, 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or a range between any two of the foregoing values ​​of matricaria flower extract, mallow flower extract, peony root extract, honeysuckle flower extract, dandelion rhizome / root extract, Viola yedoensis extract, and aloe barbadensis leaf juice;

[0098] Glyceryl glucoside 0.1%, 0.15%, 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 0.55%, 0.6%, 0.65%, 0.7%, 0.75%, 0.8%, 0.85%, 0.9%, 1% or the range between any two of the foregoing values;

[0099] Tetrapeptide-1 0.0005%, 0.0006%, 0.0007%, 0.0008%, 0.0009%, 0.001%, 0.0012%, 0.0015%, 0.0018%, 0.002% or the range between any two of the foregoing values;

[0100] Glycosphingolipids: 0.0005%, 0.0006%, 0.0007%, 0.0008%, 0.0009%, 0.001%, 0.0012%, 0.0015%, 0.0018%, 0.002% or the range between any two of the foregoing values;

[0101] Sea cucumber polypeptide solution 0.01%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1% or the range between any two of the foregoing values;

[0102] 0.01%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1% or the range between any two of the foregoing values ​​of the recombinant collagen solution; and the balance is water.

[0103] Further optionally, in some embodiments of the present application, in the recombinant collagen solution, the mass concentration of the recombinant collagen is 0.01 mg / mL-5 mg / mL.

[0104] In the above technical solution, the mass concentration of recombinant collagen in the recombinant collagen solution is set to 0.01 mg / mL-5 mg / mL; within the above range, the proliferation and healing potential of skin cells can be effectively improved; therefore, it is beneficial to improve the skin damage repair ability.

[0105] Illustratively, in some embodiments of the present application, in the recombinant collagen solution, the mass concentration of recombinant collagen is 0.01 mg / mL, 0.02 mg / mL, 0.03 mg / mL, 0.05 mg / mL, 0.08 mg / mL, 0.09 mg / mL, 0.1 mg / mL, 0.2 mg / mL, 0.5 mg / mL, 0.8 mg / mL, 1 mg / mL, 1.5 mg / mL, 2 mg / mL, 2.5 mg / mL, 3 mg / mL, 3.5 mg / mL, 4 mg / mL, 4.5 mg / mL, 5 mg / mL or a range between any two of the foregoing values.

[0106] Further optionally, in some embodiments of the present application, in the recombinant collagen solution, the mass concentration of the recombinant collagen is 0.01 mg / mL-0.1 mg / mL.

[0107] Further optionally, in some embodiments of the present application, the recombinant collagen includes at least one of type I recombinant collagen and type III recombinant collagen.

[0108] Illustratively, in some embodiments of the present application, the recombinant collagen is selected from: any one of type I recombinant collagen and type III recombinant collagen.

[0109] Or in some embodiments of the present application, the recombinant collagen selected is: a mixture of type I recombinant collagen and type III recombinant collagen; the various raw materials in the mixture can be mixed in any proportion.

[0110] In the above technical solution, a recombinant collagen solution is used, which is consistent with the sequence of human collagen and is more conducive to human skin absorption, thereby being able to better improve the skin elasticity and skin care function.

[0111] Furthermore, in some embodiments of the present application, the recombinant collagen is in a chimeric form of type I and type III collagen.

[0112] Illustratively, in some embodiments of the present application, the amino acid sequence of the above-mentioned recombinant collagen includes amino acids 950-1075 of type I collagen, and amino acids 594-729 and 1193-1199 of type III collagen.

[0113] Optionally, in some embodiments of the present application, the above-mentioned recombinant collagen can adopt the recombinant collagen in Chinese Patent 202310123476.3.

[0114] Optionally, in some embodiments of the present application, the above-mentioned recombinant collagen can be purchased commercially.

[0115] Furthermore, in some embodiments of the present application, in the sea cucumber polypeptide solution, the molar concentration of the sea cucumber polypeptide is 1 μmol / L-10 μmol / L.

[0116] In the above technical scheme, by setting the molar concentration of sea cucumber polypeptide in the sea cucumber polypeptide solution to 1μmol / L-10μmol / L; within the above range, it can cooperate with recombinant collagen and schizophyllan solution to achieve a synergistic effect, thereby effectively improving the proliferation and healing potential of skin cells; and thus greatly helping to improve the skin damage repair ability.

[0117] Illustratively, in some embodiments of the present application, in the sea cucumber polypeptide solution, the molar concentration of the sea cucumber polypeptide is 1 μmol / L, 1.5 μmol / L, 2 μmol / L, 2.5 μmol / L, 3 μmol / L, 3.5 μmol / L, 4 μmol / L, 4.5 μmol / L, 5 μmol / L, 5.5 μmol / L, 6 μmol / L, 6.5 μmol / L, 7 μmol / L, 7.5 μmol / L, 8 μmol / L, 8.5 μmol / L, 9 μmol / L, 9.5 μmol / L, 10 μmol / L or a range between any two of the foregoing values.

[0118] Furthermore, in some embodiments of the present application, in the sea cucumber polypeptide solution, the molecular weight of the sea cucumber polypeptide is 900Da to 1000Da.

[0119] In the above technical scheme, by setting the molecular weight of the sea cucumber polypeptide in the sea cucumber polypeptide solution to 900Da~1000Da; within the above range, it can cooperate with the recombinant collagen and schizophyllan solution to achieve a synergistic effect, thereby effectively improving the proliferation and healing potential of skin cells; and thus greatly helping to improve the skin damage repair ability.

[0120] Illustratively, in some embodiments of the present application, in the sea cucumber polypeptide solution, the molecular weight of the sea cucumber polypeptide is 900Da, 910Da, 920Da, 930Da, 940Da, 950Da, 960Da, 970Da, 980Da, 990Da, 1000Da or a range between any two of the foregoing values.

[0121] Furthermore, in some embodiments of the present application, in the Schizophyllan solution, the mass concentration of Schizophyllan is 20 μg / mL to 800 μg / mL.

[0122] In the above technical scheme, by setting the mass concentration of Schizophyllan in the Schizophyllan solution to 20μg / mL~800μg / mL; within the above range, it can cooperate with recombinant collagen and Schizophyllan solution to achieve a synergistic effect, thereby effectively improving the proliferation and healing potential of skin cells; and thus greatly helping to improve the skin damage repair ability.

[0123] Illustratively, in some embodiments of the present application, in the Schizophyllan solution, the mass concentration of Schizophyllan is 20 μg / mL, 30 μg / mL, 50 μg / mL, 80 μg / mL, 100 μg / mL, 150 μg / mL, 200 μg / mL, 300 μg / mL, 500 μg / mL, 600 μg / mL, 700 μg / mL, 750 μg / mL, 800 μg / mL or a range between any two of the foregoing values.

[0124] Furthermore, in some embodiments of the present application, in the Schizophyllan solution, the mass concentration of Schizophyllan is 200 μg / mL to 600 μg / mL.

[0125] Illustratively, in some embodiments of the present application, in the Schizophyllan solution, the mass concentration of Schizophyllan is 200 μg / mL, 210 μg / mL, 220 μg / mL, 250 μg / mL, 280 μg / mL, 300 μg / mL, 350 μg / mL, 400 μg / mL, 450 μg / mL, 500 μg / mL, 550 μg / mL, 580 μg / mL, 600 μg / mL or a range between any two of the foregoing values.

[0126] In some embodiments of the present application, the cosmetics for repairing skin damage containing Schizophyllan also include a preservative, such as caprylhydroxamic acid; illustratively, it can be added in the form of a mixed solution of butanediol, caprylhydroxamic acid, ethylhexylglycerol, 1,2-hexanediol, and water. The raw materials in the mixed solution can be mixed in any proportion.

[0127] Butylene glycol, caprylylhydroxamic acid, ethylhexylglycerin, 1,2-hexanediol, water

[0128] Some embodiments of the present application provide a method for preparing a cosmetic containing Schizophyllan for repairing skin damage, comprising:

[0129] Boil tetrahydromethylpyrimidine carboxylic acid, add it into water, and stir until transparent to obtain a pre-made raw material;

[0130] Add water, glycerin, panthenol, butylene glycol, glyceryl polyether-26, acrylates / C10-30 alkyl acrylate crosspolymer, dipotassium glycyrrhizinate, schizophyllan solution, and rice fermentation product filtrate into a water phase pot, raise the temperature to 80-90° C., and keep the temperature for 5-15 minutes to obtain a first mixture;

[0131] The first mixture is added into an emulsifying pot and homogenized to obtain a second mixture;

[0132] Cooling the second mixture to 40-50° C.; adding the pre-prepared raw materials, ascorbyl palmitate, lactobacillus / soy milk fermentation product filtrate, chamomile flower extract, malva sylvestris flower extract, peony root extract, honeysuckle flower extract, dandelion rhizome / root extract, Viola yedoensis extract, a mixture of aloe vera leaf juice, glyceryl glucoside, tetrapeptide-1, glycosphingolipids, sea cucumber polypeptide solution, and recombinant collagen solution, and homogenizing to obtain a third mixture;

[0133] The third mixture was cooled to 30-40°C.

[0134] The above preparation method can produce any of the aforementioned embodiments of the cosmetics for repairing skin damage containing Schizophyllan.

[0135] Furthermore, in some embodiments of the present application, a method for preparing a cosmetic containing Schizophyllan for repairing skin damage comprises:

[0136] Step S1, boiling tetrahydromethylpyrimidine carboxylic acid, adding it into water, and stirring until transparent to obtain a prefabricated raw material.

[0137] Exemplarily, in some embodiments of the present application, the above-mentioned prefabricated raw material preparation includes:

[0138] Add ectoine to boiled water cooled to room temperature, stir until transparent, and set aside.

[0139] Step S2: preparing a first mixture.

[0140] In some embodiments of the present application, preparing the first mixture includes:

[0141] Add water, glycerin, panthenol, butylene glycol, glyceryl polyether-26, acrylates / C10-30 alkyl acrylate crosspolymer, dipotassium glycyrrhizate, schizophyllan solution, and rice fermentation product filtrate into an aqueous phase pot, heat to 80-90° C., and keep warm for 5-15 minutes to obtain a first mixture.

[0142] Exemplarily, in some embodiments of the present application, preparing the first mixture includes:

[0143] Add water, glycerin, panthenol, butylene glycol, glyceryl polyether-26, acrylates / C10-30 alkyl acrylate crosspolymer, dipotassium glycyrrhizinate, schizophyllan solution, and rice fermentation product filtrate into an aqueous phase pot, and heat to 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C or in a range between any two of the aforementioned values; keep warm for 5 min, 6 min, 7 min, 8 min, 9 min, 10 min, 11 min, 12 min, 13 min, 14 min, 15 min or in a range between any two of the aforementioned values ​​to obtain a first mixture.

[0144] Step S3: preparing a second mixture.

[0145] The first mixture is added into an emulsifying pot and homogenized to obtain a second mixture;

[0146] Step S4: preparing a third mixture.

[0147] Cooling the second mixture to 40-50° C.; adding the pre-prepared raw materials, ascorbyl palmitate, lactobacillus / soy milk fermentation product filtrate, chamomile flower extract, malva sylvestris flower extract, peony root extract, honeysuckle flower extract, dandelion rhizome / root extract, Viola yedoensis extract, a mixture of aloe vera leaf juice, glyceryl glucoside, tetrapeptide-1, glycosphingolipids, sea cucumber polypeptide solution, and recombinant collagen solution, and homogenizing to obtain a third mixture;

[0148] Exemplarily, in some embodiments of the present application, preparing the third mixture includes:

[0149] Cooling the second mixture to 40°C, 41°C, 42°C, 43°C, 44°C, 45°C, 46°C, 47°C, 48°C, 49°C, 50°C or a range between any two of the foregoing values; adding a mixture of prefabricated raw materials, ascorbyl palmitate, lactobacillus / soy milk fermentation product filtrate, chamomile flower extract, mallow flower extract, peony root extract, honeysuckle flower extract, dandelion rhizome / root extract, Viola yedoensis extract, aloe vera leaf juice, glycerol glucoside, tetrapeptide-1, glycosphingolipids, sea cucumber polypeptide solution, and recombinant collagen solution, and homogenizing to obtain a third mixture;

[0150] Step S5, cooling the third mixture to 30°C to 40°C.

[0151] Illustratively, in some embodiments of the present application, the third mixture is cooled to 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, 40°C or a range between any two of the foregoing values.

[0152] Exemplarily, in some embodiments of the present application, a method for preparing a cosmetic containing Schizophyllan for repairing skin damage comprises:

[0153] Add tetrahydromethylpyrimidine carboxylic acid into boiled water cooled to room temperature, stir until transparent, and set aside to obtain preformed raw material A.

[0154] Add water to the water phase pot, start stirring at 800-2000 rpm, add glycerin, panthenol, butylene glycol, glyceryl polyether-26, acrylates / C10-30 alkyl acrylate crosspolymer, dipotassium glycyrrhizate, schizophyllan solution, and rice fermentation product filtrate, raise the temperature to (85±1)°C, and keep warm for 5-15 minutes;

[0155] Start the emulsification pot and stir at 30-40 rpm, pump the water phase into the emulsification pot, evacuate to -(0.04±0.01)Mpa, start the external circulation homogenization, homogenize for 1-5 minutes, and the homogenization speed is 800-2000 rpm; after the homogenization is completed, keep warm and stir for 5-15 minutes, add the raw materials aminomethyl propanol and water, and start cooling;

[0156] Maintain vacuum - (0.04 ± 0.01) MPa, stirring speed of 30 ~ 45 rpm, cool to (45 ± 1) ° C, add prefabricated raw material A, ascorbyl palmitate, lactobacillus / soy milk fermentation product filtrate, chamomile flower extract, European mallow flower extract, peony root extract, honeysuckle flower extract, European dandelion rhizome / root extract, Viola yedoensis extract, aloe vera leaf juice mixture, glycerol glucoside, tetrapeptide-1, glycosphingolipids, sea cucumber polypeptide solution, recombinant collagen solution, keep stirring for 5 ~ 15 minutes, start external circulation homogenization for 10 ~ 25 seconds, homogenization speed 1000 ~ 2500 rpm.

[0157] Further, in some embodiments of the present application, preparing the Schizophyllan solution comprises:

[0158] removing the bacterial bodies from the Schizophyllum fermentation liquid to obtain a fermentation supernatant;

[0159] The fermentation supernatant is decolorized, deproteinized and desalted to obtain a transparent fermentation supernatant;

[0160] Concentrating the transparent fermentation supernatant to 30% to 50% of the volume of the original solution to obtain a concentrated liquid;

[0161] removing free proteins from the concentrated liquid to obtain a schizophyllan solution;

[0162] The schizophyllan solution is subjected to alcohol precipitation to obtain a deproteinized flocculent polysaccharide; the deproteinized flocculent polysaccharide is redissolved to obtain a reconstituted liquid; the reconstituted liquid is dialyzed and freeze-dried to obtain a powder; and the powder is redissolved with water.

[0163] Illustratively, the transparent fermentation supernatant is concentrated to 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50% of the volume of the original liquid or a range between any two of the foregoing values ​​to obtain a concentrated liquid.

[0164] Exemplarily, in some embodiments of the present application, preparing a Schizophyllan solution comprises: comprising the following steps:

[0165] (1) Removing Schizophyllum cells: The fermentation liquid is centrifuged in a high-speed tubular centrifuge to remove the cells (20,000 r / min, 20 min) to obtain a fermentation supernatant;

[0166] (2) Removal of pigments, impurities, and salts by macroporous resin: Take 500 ml of Schizophyllan, add 1%-5% AMP-277 activated macroporous resin, stir in a 70°C constant temperature water bath for 30 min to decolorize, deproteinize, and remove salts, then remove the macroporous resin by centrifuge (4000 r / min, 20 min), and further vacuum filter with filter paper to obtain a transparent fermentation supernatant;

[0167] (3) Concentrating the fermentation broth: Use a 70°C vacuum pump to concentrate the decolorized supernatant to about 200 ml (stock solution: concentrated solution = 5:2).

[0168] (4) The concentrate is subjected to the sevag method to remove free proteins: a chloroform-n-butanol mixed solution is added to the crude polysaccharide solution and shaken thoroughly to denature the free proteins into insoluble substances, which are then removed by centrifugation to achieve the purpose of removal. The specific operation is as follows: 20 ml of the above concentrate and 10 ml of chloroform-n-butanol (pre-configured into a mixed solution with a volume ratio of 4:1) are placed in a 50 mL stoppered centrifuge tube at a volume ratio of 2:1 and mixed evenly. The mixture is shaken vigorously for 30 min, transferred to a centrifuge tube and centrifuged at 4000 r / min for 20 min, the aqueous phase and the chloroform phase are separated, the intermediate denatured protein and the lower organic solution layer are removed by separation, the upper aqueous phase is added with the chloroform-n-butanol solution again, and the above process is repeated 3 times until no white flocs appear in the organic solvent layer (the intermediate denatured protein layer no longer appears).

[0169] (5) The above solution was then precipitated with 2 times 95% ethanol at 4°C for 24 h to obtain deproteinized flocculent polysaccharide, which was washed with 5 mL of 95% ethanol and then redissolved in 15 mL of distilled water (stock solution: distilled water = 4:1). The schizophyllan solution was dialyzed with running water for 24 h and with distilled water for 24 h, respectively, and freeze-dried to obtain refined schizophyllan.

[0170] Some embodiments of the present application provide a composition comprising Schizophyllan, including:

[0171] Schizophyllum polysaccharide, sea cucumber polypeptide, recombinant collagen;

[0172] The mass concentration of recombinant collagen is 0.01-5 mg / mL;

[0173] The molar concentration of sea cucumber polypeptides is 1μmol / L-10μmol / L;

[0174] The mass concentration of Schizophyllan is 20 μg / mL to 800 μg / mL.

[0175] The above-mentioned composition containing Schizophyllan, with the various raw materials coordinated in a synergistic manner, can effectively improve the proliferation and healing potential of skin cells within the above-mentioned range; thus, it is beneficial to improve the skin damage repair ability.

[0176] Exemplarily, in some embodiments of the present application, a composition containing Schizophyllan is provided, comprising:

[0177] Schizophyllum polysaccharide, sea cucumber polypeptide, recombinant collagen;

[0178] The mass concentration of the recombinant collagen is 0.01 mg / mL, 0.02 mg / mL, 0.03 mg / mL, 0.05 mg / mL, 0.08 mg / mL, 0.1 mg / mL, 0.5 mg / mL, 1 mg / mL, 2 mg / mL, 3 mg / mL, 4 mg / mL, 4.5 mg / mL, 5 mg / mL or a range between any two of the foregoing values;

[0179] The molar concentration of the sea cucumber polypeptide is 1 μmol / L, 1.2 μmol / L, 1.5 μmol / L, 1.8 μmol / L, 2 μmol / L, 3 μmol / L, 4 μmol / L, 5 μmol / L, 6 μmol / L, 7 μmol / L, 8 μmol / L, 9 μmol / L, 10 μmol / L or a range between any two of the foregoing values;

[0180] The mass concentration of schizophyllan is 20 μg / mL, 30 μg / mL, 40 μg / mL, 50 μg / mL, 80 μg / mL, 100 μg / mL, 150 μg / mL, 200 μg / mL, 250 μg / mL, 300 μg / mL, 350 μg / mL, 400 μg / mL, 500 μg / mL, 600 μg / mL, 700 μg / mL, 750 μg / mL, 780 μg / mL, 800 μg / mL or the range between any two of the foregoing values.

[0181] The features and performance of the present application are further described in detail below in conjunction with the embodiments:

[0182] Example 1

[0183] Provided is an essence for repairing skin damage containing Schizophyllan, with the proportions shown in Table 1 by weight:

[0184] Table 1

[0185]

[0186]

[0187]

[0188] Note: In the above table, the SPG concentration is 600μg / mL, the sea cucumber polypeptide concentration is 5μM (0.49mg / mL), and the mixed type I and III collagen concentration is 0.1mg / mL.

[0189] Preparation process:

[0190] 1. Prefabrication:

[0191] Preparing (A): Add the raw material (12) to the raw material (11) that has been boiled and cooled to room temperature, stir until transparent, and set aside.

[0192] (II) Production process:

[0193] 1. Add raw material (1) into the water phase pot, start stirring at 1000 rpm, add (2), (3), (4), (5), (6), (7), (8), (9), raise the temperature to (85±1)°C, and keep warm for 10 minutes;

[0194] 2. Turn on the emulsification pot and stir at 35 rpm, pump the water phase into the emulsification pot, evacuate to -(0.04±0.01)Mpa, turn on the external circulation homogenization, homogenize for 2 minutes, and the homogenization speed is 2000 rpm; after the homogenization is completed, keep warm and stir for 10 minutes, add raw material (10), and start cooling;

[0195] 3. Maintain vacuum - (0.04 ± 0.01) MPa, stirring speed at 35 rpm, when the temperature drops to (45 ± 1) °C, add pre-made (A) and raw materials with sequence numbers (13), (14), (15), (16), (17), (18), (19), (20), (21), keep stirring for 10 min, start external circulation homogenization for 20 s, homogenization speed at 2000 rpm;

[0196] 4. When the temperature drops to (38±1)℃, take samples for inspection. If qualified, the material will be discharged through 300-mesh filter cloth.

[0197] (Do not store in metal containers).

[0198] 1. Test the repair efficacy of samples of Example 1 and Comparative Example 1.

[0199] The test steps are as follows:

[0200] 33 healthy female volunteers aged 25 to 45 with no history of allergies were selected to test the repairing effects of the essence water of the embodiments and comparative examples.

[0201] All subjects have signed informed consent. The inner side of the left and right forearms of the subjects were used as the test site for immediate testing, and the stratum corneum water content of the skin was compared before and 30 minutes after using the product. The test product was tested at 2.0±0.1mg / cm 2 Use a latex finger cot to evenly coat the sample on (2cm 2 ×2cm 2 ) In the test area, MPA580 CM825 and MPA4 CM825 instruments were used for testing.

[0202] The data of the stratum corneum water content growth rate (%) and transepidermal water loss rate (TEWL) after the test subjects used the embodiments and comparative examples are shown in Table 2. Skin repair efficacy index: The stratum corneum water content and the transepidermal water loss rate affect the skin's moisturizing and skin barrier efficacy; the higher the improvement of these two indicators, the better the skin repair efficacy.

[0203] Table 2

[0204]

[0205]

[0206] Test conclusion:

[0207] From the experimental data in the above table, we can see that:

[0208] Under the test conditions, after 21 days of trial use, the water content of the stratum corneum of the inner side of the arm of the sample of Example 1 increased significantly (P < 0.05), and the difference before and after was significantly improved compared with the control side of Example 1 (P < 0.05), indicating that the test product of Example 1 has a moisturizing effect.

[0209] Under the conditions of this test, after 21 days of trial use, the transepidermal water loss rate of the skin on the inner arm of the sample side of Example 1 was significantly reduced (P < 0.05), and the difference before and after was significantly improved compared with the control side (P < 0.05), indicating that the test substance of Example 1 has the effect of improving the skin barrier.

[0210] In summary, under the conditions of this experiment, the test substance in Example 1 has a repairing effect.

[0211] Both Example 2 and Example 3 contain SPG concentration, sea cucumber polypeptide concentration, and mixed collagen types I and III; and have similar repair effects as Example 1.

[0212] 2. Optimization experiment of Schizophyllan solution (SPG) concentration, sea cucumber polypeptide concentration, and type I and III mixed collagen concentration:

[0213] 1. Proliferation experiment 1

[0214] The specific experimental steps are as follows:

[0215] 5.0×10 3 HaCaT cells (human skin fibroblasts) were seeded in a 96-well plate at a density of 100 μg / mL. The cells were cultured to a confluence of about 80%. 24 hours after seeding, the purified SPG was dissolved in complete culture medium (3 mg / mL) to a final concentration of 10-300 μg / mL. CCK8 reagent was added 24 hours later and incubated at 37°C for 1 hour. The absorbance was measured at 450 nm.

[0216] The CCK8 kit is a rapid, highly sensitive kit based on WST-8 and widely used in cell activity and cytotoxicity detection. WST-8 is a compound similar to MTT. In the presence of an electron coupling reagent, it can be reduced to orange-yellow formazan by some dehydrogenases in the mitochondria. The more and faster the cells proliferate, the darker the color; for the same cells, the depth of the color is linearly related to the number of cells.

[0217] The test results are shown in the attached manual. Figure 1 ~Attached Figure 3 .

[0218] from Figure 1 It can be seen that 10-300μg / mL of SPG has an effect on the proliferation of HaCaT cells, and SPG has a concentration-dependent effect on the proliferation of HaCaT cells in the concentration range of 10-200μg / mL, indicating that increasing the concentration of SPG can enhance the proliferation of HaCaT cells, and reach a peak at 200μg / mL, and further increasing the concentration does not significantly improve the proliferation effect of HaCaT cells. In the concentration range of 200-300μg / mL, compared with the blank group, the experimental group significantly enhanced the proliferation of BJ cells (P<0.05), and the maximum proliferation rate was 140.51%.

[0219] from Figure 2It can be seen that the active peptides extracted from the marine organism sea cucumber have an effect on the proliferation of HaCaT cells, and the peak proliferation rate of HaCaT cells reached 143.56% when the sea cucumber peptide was 5μM. Continuing to increase the concentration did not significantly improve the proliferation effect of HaCaT cells, and when the concentration increased to 30-40μM, the proliferation effect on HaCaT weakened, but still reached 123.34%, significantly higher than the blank group (P<0.05). This shows that the sea cucumber peptide is an excellent material for promoting skin cell proliferation.

[0220] from Figure 3 It can be seen that the recombinantly expressed mixed type I and III collagens have an effect on the proliferation of HaCaT cells. Compared with the blank group, the recombinant collagen in the experimental group showed a concentration-dependent effect on the proliferation of HaCaT cells within the concentration range of 0.01-5 mg / mL, reaching a peak value at a concentration of 5 mg / mL, with a proliferation rate of 162.31%. The experimental group significantly enhanced the proliferation of HaCaT cells (P<0.05), indicating that increasing the concentration of recombinant collagen can promote the proliferation of HaCaT cells.

[0221] 2. Proliferation experiment 2

[0222] The specific experimental steps are as follows:

[0223] 5.0×10 3 The cells were inoculated at a density of 10 cells / mL in a 96-well plate and the cells were cultured to a confluence of about 80%. After 24 h, the schizophyllan solution (3 mg / mL) was diluted with complete culture medium to make the final concentrations of schizophyllan 20, 40, 80, 120, 200, 280, 400, 600, 800, 1000, and 1200 μg / mL, respectively. The BJ cells were treated with the culture medium containing different concentrations of schizophyllan, and CCK8 reagent was added after 24 hours. The cells were incubated at 37°C for 1 hour, and the absorbance was measured at a wavelength of 450 nm.

[0224] The CCK8 kit is a rapid, highly sensitive kit based on WST-8 and widely used in cell activity and cytotoxicity detection. WST-8 is a compound similar to MTT. In the presence of an electron coupling reagent, it can be reduced to orange-yellow formazan by some dehydrogenases in the mitochondria. The more and faster the cells proliferate, the darker the color; for the same cells, the depth of the color is linearly related to the number of cells.

[0225] The test results are shown in the attached manual. Figure 4 ~Attached Figure 6 .

[0226] from Figure 4It can be seen that after the fermentation broth was purified and re-dissolved, different concentrations of SPG had an effect on the proliferation of BJ cells, and the effect of SPG on the proliferation of BJ cells in the concentration range of 20-280μg / mL gradually decreased with the increase of polysaccharide concentration. Continuing to increase the concentration to 400μg / mL can significantly improve the proliferation effect of BJ cells, and the maximum proliferation rate is 188.82%. In the range of 400-1200μg / mL, with the increase of concentration, the effect on the proliferation of BJ cells gradually weakened, but it was still significantly higher than the blank control group (P<0.05).

[0227] from Figure 5 It can be seen that the active peptides extracted from the marine organism sea cucumber have a more prominent effect on the proliferation of BJ cells in a narrow concentration range. The sea cucumber peptide gradually increases with the concentration in the concentration range of 0.1-3.0μM, and reaches a maximum proliferation rate of 139.88% at 3.0μM. When the concentration is 3.0-40.0μM, the proliferation effect on HaCaT cells is significantly less than 3.0μM, and even after the concentration is increased to 10μM, it has an inhibitory effect on the proliferation of HaCaT, compared with the blank group (P<0.05).

[0228] from Figure 6 It can be seen that the recombinantly expressed mixed type I and III collagen had no significant promoting effect on BJ cell proliferation at 0.0001-0.005 mg / mL (P>0.05), but had a significant promoting effect on BJ cell proliferation at 0.05-0.5 mg / mL (P<0.05), and had a maximum proliferation rate of 162.31% at 0.05 mg / mL, and had no promoting effect on BJ cell proliferation at 2.5-5 mg / mL.

[0229] In summary, the concentration of schizophyllan solution (10-800 μg / mL), the concentration of recombinant collagen (0.01-5 mg / mL), and the concentration of sea cucumber polypeptide (molecular weight 900Da-1000Da) (0.1-40 μM) are beneficial to the proliferation of HaCaT cells and BJ cells. Further optionally, the concentration of schizophyllan solution (200-600 μg / mL), the concentration of recombinant collagen (0.01-0.1 mg / mL), and the concentration of sea cucumber polypeptide (molecular weight 980Da) (0.1-5 μM) are beneficial to the proliferation of HaCaT cells and BJ cells.

[0230] 3. Response surface experiment of BJ cell proliferation rate

[0231] The specific experimental steps are as follows:

[0232] 5.0×10 3The cells were inoculated in a 96-well plate at a density of 10 cells, and the cells were cultured until the confluence was about 80%. After 24 hours, schizophyllan, sea cucumber polypeptides, and recombinant collagen were added to the complete culture medium. The corresponding levels of each experimental influencing factor are shown in Table 3. The above culture medium with different concentrations of schizophyllan, sea cucumber polypeptides, and recombinant collagen were used to treat BJ cells, and CCK8 reagent was added after 24 hours, and incubated at 37°C for 1 hour, and the absorbance was measured at a wavelength of 450nm.

[0233] Table 3 Experimental factors and levels

[0234]

[0235] Table 4 The results of Box–Behnken response surface analysis on the effects of formulations on cell proliferation

[0236]

[0237]

[0238] According to the response surface analysis experiment, the effects of different concentrations of SPG, sea cucumber polypeptide and recombinant collagen on the proliferation of BJ cells are shown in Table 4.

[0239] Table 5 Analysis of variance of recipe optimization fitting model

[0240]

[0241]

[0242] The variance analysis of the response surface experiment is shown in Table 5. The model P value is 0.0410<0.05, indicating that the model is significant, and the Lack of Fit P value is 0.0641>0.05, which is not significant. The interaction between the peptide concentration and the recombinant collagen concentration is significant, R (%) = 153.43 + 8.59A-8.68B + 7.34C + 6.92AB-3.22AC-3.76BC + 13.43A 2 -13.14B 2 +9.38C 2 (R 2 =0.837).

[0243] The response surface of BJ cell proliferation of the three materials is shown in the attached figure. Figure 7-9 shown.

[0244] Figure 7 , 8Figure 9 is a 3D diagram of the response surface analysis experiment. Combined with the above experimental results, the Box-Behnken optimization test was used to conduct a 3-factor 3-level experiment, and the response surface analysis was performed with the proliferation rate of BJ cells as the response value. The results showed that the optimal formula for wound repair was: SPG concentration 600μg / mL, sea cucumber polypeptide concentration 5μM (0.49mg / mL), and mixed type I and III collagen concentration 0.1mg / mL, which had the strongest effect on promoting the proliferation of BJ cells.

[0245] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. A cosmetic comprising Schizophyllan for repairing skin damage, characterized in that: 100% quality, including: Glycerol 5%-15%; Panthenol 0.5%-1.5%; Butanediol 1% to 5%; Glyceryl polyether-26 1%~5%; Acrylic acid (esters) / C10-30 alkyl acrylate crosspolymer 0.1% to 0.5%; Dipotassium glycyrrhizinate 0.1%~0.5%; Schizophyllan solution 2% to 10%; Rice fermentation product filtrate 0.5% to 1.5%; Aminomethyl propanol solution 0.01% to 0.1%; Tetrahydromethylpyrimidine carboxylic acid 0.5% to 1.5%; Ascorbyl palmitate 0.0005% to 0.002%; Lactobacillus / soy milk fermentation product filtrate 0.0005% to 0.002%; 0.1% to 1% mixture of chamomile flower extract, mallow flower extract, peony root extract, honeysuckle flower extract, dandelion rhizome / root extract, Viola yedoensis extract, and aloe barbadensis leaf juice; Glyceryl glucoside 0.1% to 1%; Tetrapeptide-1 0.0005%~0.002%; Glycosphingolipids 0.0005% to 0.002%; Sea cucumber polypeptide solution 0.01%~0.1%; 0.01% to 0.1% recombinant collagen solution; and the balance water.

2. The cosmetic for repairing skin damage comprising Schizophyllan according to claim 1, characterized in that: In the recombinant collagen solution, the mass concentration of the recombinant collagen is 0.01 mg / mL-5 mg / mL; Optionally, in the recombinant collagen solution, the mass concentration of the recombinant collagen is 0.01 mg / mL-0.1 mg / mL.

3. The cosmetic for repairing skin damage comprising Schizophyllan according to claim 2, characterized in that: The recombinant collagen includes at least one of type I recombinant collagen and type III recombinant collagen.

4. The cosmetic for repairing skin damage comprising Schizophyllan according to claim 1, characterized in that: In the sea cucumber polypeptide solution, the molar concentration of the sea cucumber polypeptide is 0.1 μmol / L-40 μmol / L; optionally, in the sea cucumber polypeptide solution, the molar concentration of the sea cucumber polypeptide is 1 μmol / L-5 μmol / L.

5. The cosmetic for repairing skin damage comprising Schizophyllan according to claim 4, characterized in that: In the sea cucumber polypeptide solution, the molecular weight of the sea cucumber polypeptide is 900Da-1000Da.

6. The cosmetic for repairing skin damage comprising Schizophyllan according to claim 1, characterized in that: In the Schizophyllan solution, the mass concentration of Schizophyllan is 10 μg / mL to 800 μg / mL.

7. The cosmetic for repairing skin damage comprising Schizophyllan according to claim 1, characterized in that: In the Schizophyllan solution, the mass concentration of Schizophyllan is 200 μg / mL to 600 μg / mL.

8. The method for preparing a cosmetic for repairing skin damage comprising Schizophyllan according to any one of claims 1 to 7, characterized in that: include: Boil tetrahydromethylpyrimidine carboxylic acid, add it into water, and stir until transparent to obtain a preformed raw material; Add water, glycerin, panthenol, butylene glycol, glyceryl polyether-26, acrylates / C10-30 alkyl acrylate crosspolymer, dipotassium glycyrrhizinate, schizophyllan solution, and rice fermentation product filtrate into a water phase pot, raise the temperature to 80-90° C., and keep the temperature for 5-15 minutes to obtain a first mixture; Add the first mixture into an emulsifying pot and homogenize to obtain a second mixture; Cooling the second mixture to 40-50° C.; adding the prefabricated raw materials, ascorbyl palmitate, lactobacillus / soy milk fermentation product filtrate, chamomile flower extract, malva sylvestris flower extract, peony root extract, honeysuckle flower extract, dandelion rhizome / root extract, Viola yedoensis extract, a mixture of aloe vera leaf juice, glycerol glucoside, tetrapeptide-1, glycosphingolipids, sea cucumber polypeptide solution, and recombinant collagen solution, and homogenizing to obtain a third mixture; The third mixture is cooled to 30°C to 40°C.

9. The method for preparing a cosmetic for repairing skin damage comprising Schizophyllan according to claim 8, characterized in that: include: The preparation of the Schizophyllan solution comprises: removing the bacterial bodies from the Schizophyllum fermentation liquid to obtain a fermentation supernatant; Decolorizing, deproteinizing and desalting the fermentation supernatant to obtain a transparent fermentation supernatant; Concentrating the transparent fermentation supernatant to 30% to 50% of the volume of the original solution to obtain a concentrated liquid; removing free protein from the concentrated liquid to obtain a Schizophyllan solution; The schizophyllan solution is subjected to alcohol precipitation to obtain a deproteinized flocculent polysaccharide; the deproteinized flocculent polysaccharide is redissolved to obtain a reconstituted liquid; the reconstituted liquid is dialyzed and freeze-dried to obtain a powder; and the powder is redissolved with water.

10. A composition comprising Schizophyllan, characterized in that include: Schizophyllum polysaccharide, sea cucumber polypeptide, recombinant collagen; The mass concentration of the recombinant collagen is 0.01-5 mg / mL; The molar concentration of the sea cucumber polypeptide is 1 μmol / L-10 μmol / L; The mass concentration of the schizophyllan is 20 μg / mL to 800 μg / mL.

Citation Information

Patent Citations

  • Method for preparing Schizophyllum commune Fr polysaccharides and dedicated culture medium thereof

    CN101643759A

  • Sea cucumber extract nourishing mask and making method thereof

    CN108042470A

  • Restoring lotion and preparing method thereof

    CN110339151A

  • Composition for promoting transdermal absorption of polypeptide and application thereof in skin care products

    CN113893183A

  • Whitening peptide with repairing effect as well as preparation method and application thereof

    CN117343198A